1 min read
Understanding Regulatory Timelines in Colombia
In Colombia, regulatory timelines for pharmaceutical products are established by law and supported by official frameworks defined by INVIMA.
These timelines assume that submissions meet all regulatory expectations from the outset. In practice, however, review processes are frequently extended due to additional information requests issued during evaluation.
What Triggers INVIMA Requests?
Regulatory requests are typically issued when submitted dossiers do not fully align with local requirements or when additional clarification is needed.
Common triggers include:
- Incomplete or inconsistent documentation
- Misalignment with local classification criteria
- Gaps between global data and local expectations
- Insufficient justification of technical or clinical information
In many cases, these requests are not the result of critical deficiencies, but rather differences in how regulatory data is interpreted within the Colombian framework.
The Impact of Requests on Timelines
Each request issued by INVIMA pauses the review process until the applicant provides a response.
This can result in:
- Extended approval timelines
- Increased operational complexity
- Additional coordination between global and local teams
As a result, the actual time to approval may differ significantly from the expected timelines defined in regulatory frameworks.
How to Reduce the Risk of Delays
While regulatory requests are a standard part of the evaluation process, their frequency and impact can be reduced through proactive planning.
Key considerations include:
- Aligning submissions with local regulatory expectations from the beginning
- Identifying gaps between global dossiers and Colombian requirements
- Anticipating areas where additional justification may be required
- Structuring submissions to support a clearer and more efficient review
From Reactive to Controlled Regulatory Pathways
Regulatory delays are not always driven by complexity—they are often linked to avoidable gaps in submission readiness.
A more effective approach involves shifting from reactive responses to proactive regulatory planning, focusing on how submissions will be evaluated in practice rather than how they are compiled.
Regulatory timelines in Colombia are structured, but they are not always predictable in practice. INVIMA requests play a central role in shaping the actual duration of the review process.
Reducing delays requires more than meeting formal requirements—it requires anticipating how dossiers will be interpreted during evaluation.
Anticipating potential risks, structuring submissions, and aligning regulatory strategies with Colombia’s framework is not simply a matter of optimization—it is what defines whether a regulatory pathway remains controlled or becomes uncertain.
If your organization is preparing submissions in Colombia and looking to reduce INVIMA-driven delays, connect with Freyr to assess your dossier’s readiness before it enters evaluation. contact
